Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Arnulf Willms, Clara Müller, Henrike Julich, Niklas Klein, Robert Schwab, Christoph Güsgen, Ines Richardsen, Sebastian Schaaf, Marcin Krawczyk, Marek Krawczyk, Frank Lammert, Detlef Schuppan, Veronika Lukacs-Kornek, Miroslaw Kornek
Published Apr 26, 2016 · Vol. 7, No. 21 · pp. 30867-30875
Alessandro Passardi, Emanuela Scarpi, Luigi Cavanna, Monia Dall’Agata, Davide Tassinari, Silvana Leo, Ilaria Bernardini, Fabio Gelsomino, Stefano Tamberi, Alba A. Brandes, Elena Tenti, Roberto Vespignani, Giovanni L. Frassineti, Dino Amadori, Ugo De Giorgi
Published Apr 21, 2016 · Vol. 7, No. 22 · pp. 33210-33219
Thomas V. Guy, Alexandra M. Terry, Holly A. Bolton, David G. Hancock, Erhua Zhu, Robert Brink, Helen M. McGuire, Elena Shklovskaya, Barbara Fazekas de St Groth
Published Apr 18, 2016 · Vol. 7, No. 21 · pp. 30211-30229